Hey boslo. Who knows what goes on in the privacy of one's home, but we are testing on the iPPS v. placebo in the trials, to establish iPPS on it's own merits. I get your drift, but these tests must be kept on a strict schedule of only what the test calls for, to gain FDA approval. Maybe it will, but I am not certain that it has been discussed much on these threads. Adding nsaids to the testing cold add another two/three years to approval....for each one! Hope that helps somewhat.
research reports and media, page-1154
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $288.5K | 1.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 130626 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |